Nanovis Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Private

  • Employees
  • 24

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $500K

  • Investors
  • 13

Nanovis General Information

Description

Developer of nanotechnology-driven surgical implant designed to serve as a fixation choice for surgeons to heal their patients. The company's implants include nanosurfaces, nanostructured biomaterials, and bone growth peptides to design and manufacture implantable scaffolds, or injectable bio-materials with tissue growth properties, enabling surgeons to have access to a portfolio of spinal implants that offer fixation, visualization, and durability.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 5865 East State Road 14
  • Columbia, IN 46725
  • United States
+1 (877)
Primary Industry
Surgical Devices
Other Industries
Other Devices and Supplies
Therapeutic Devices
Corporate Office
  • 5865 East State Road 14
  • Columbia, IN 46725
  • United States
+1 (877)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nanovis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
16. Later Stage VC 29-Dec-2023 $500K Completed Generating Revenue
15. Later Stage VC 09-Apr-2020 Completed Generating Revenue
14. Later Stage VC 28-Aug-2018 Completed Generating Revenue
13. Later Stage VC 13-Sep-2017 Completed Generating Revenue
12. Later Stage VC 14-Dec-2015 Completed Generating Revenue
11. Later Stage VC 09-Jan-2015 Completed Generating Revenue
10. Grant 01-Jan-2015 Completed Generating Revenue
9. Later Stage VC 29-Jul-2014 Completed Generating Revenue
8. Grant 01-Jan-2014 $1.5M $395K Completed Generating Revenue
7. Later Stage VC 07-Mar-2013 $70K $395K Completed Generating Revenue
To view Nanovis’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Nanovis Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of nanotechnology-driven surgical implant designed to serve as a fixation choice for surgeons to heal their pa
Surgical Devices
Columbia, IN
24 As of 2025

Carlsbad, CA
 

Shelton, CT
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Nanovis Competitors (5)

One of Nanovis’s 5 competitors is Spinal Elements, a Private Equity-Backed company based in Carlsbad, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Spinal Elements Private Equity-Backed Carlsbad, CA
Spine Wave Venture Capital-Backed Shelton, CT
Nvision Venture Capital-Backed San Antonio, TX
Spinal Simplicity Venture Capital-Backed Overland Park, KS
Promimic Formerly VC-backed Gothenburg, Sweden
You’re viewing 5 of 5 competitors. Get the full list »

Nanovis Patents

Nanovis Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210340520-A1 Methods for stimulating the proliferation and differentiation of eukaryotic cells Pending 10-Jan-2019
US-20200368351-A1 Inactivating bacteria with electric pulses and antibiotics Active 13-Feb-2018
US-20130337028-A1 Biomimetic peptides for bone augmentation Inactive 25-Jun-2010
EP-2588489-A2 Biomimetic peptides for bone augmentation Inactive 25-Jun-2010
US-20190099519-A1 Method for producing nanosurfaces with nano, micron, and/or submicron structures on a polymer Inactive 25-Jun-2010 A61L27/18
To view Nanovis’s complete patent history, request access »

Nanovis Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nanovis Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
Global Health & Pharma Corporation Minority
1st Source Bank Corporation Minority
Commenda Capital Corporation Minority
Ellipsis Ventures Venture Capital Minority
Micropulse Corporation Minority
You’re viewing 5 of 13 investors. Get the full list »

Nanovis FAQs

  • When was Nanovis founded?

    Nanovis was founded in 2006.

  • Where is Nanovis headquartered?

    Nanovis is headquartered in Columbia, IN.

  • What is the size of Nanovis?

    Nanovis has 24 total employees.

  • What industry is Nanovis in?

    Nanovis’s primary industry is Surgical Devices.

  • Is Nanovis a private or public company?

    Nanovis is a Private company.

  • What is Nanovis’s current revenue?

    The current revenue for Nanovis is .

  • How much funding has Nanovis raised over time?

    Nanovis has raised $16.1M.

  • Who are Nanovis’s investors?

    Global Health & Pharma, 1st Source Bank, Commenda Capital, Ellipsis Ventures, and Micropulse are 5 of 13 investors who have invested in Nanovis.

  • Who are Nanovis’s competitors?

    Spinal Elements, Spine Wave, Nvision, Spinal Simplicity, and Promimic are competitors of Nanovis.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »